Pharmabiz11m
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma: Paris Tuesday, January 14, 2025, 10:00 Hrs ...
Pharmabiz1h
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments: Our Bureau, Mumbai Tuesday, January 14, 2025, 09:00 Hrs ...
Pharmabiz2h
PDMA asks govt to create separate category for units below Rs. 10 crore & allow 3 years to implement revised Schedule M
Gireesh Babu, New Delhi Tuesday, January 14, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
Pharmacy Council of India fixes staff to students ratio for B.Pharm as 1:20
The Pharmacy Council of India (PCI) has stipulated that the staff to student ratio for Bachelor of Pharmacy (B.Pharm) courses should not exceed 1:20 in theory classes and practical classes. The ...
Pharmabiz2h
HPMA demands three years’ time for full compliance with revised Schedule M
HPMA demands three years’ time for full compliance with revised Schedule M: Peethaambaran Kunnathoor, Chennai Tuesday, ...
Pharmabiz2h
India initiates anti-dumping probe on Resorcinol imports from China and Japan
India initiates anti-dumping probe on Resorcinol imports from China and Japan: Shardul Nautiyal, Mumbai Tuesday, January 14, 2025, 08:00 Hrs [IST] The Directorate General of Trade ...
Pharmabiz17h
Qiagen increases QIAcuity Digital PCR High-Order Multiplexing capabilities to gain deeper insights from biological samples
Venlo, Netherlands Monday, January 13, 2025, 17:00 Hrs [IST] ...
Pharmabiz17h
Lupin introduces Minzoya in US market
Global pharma major Lupin Limited (Lupin) announced the launch of the United States Food and Drug Administration (FDA) approved Minzoya (levonorgestrel and ethinyl estradiol tablets, USP and ferrous ...
Pharmabiz17h
Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia
Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia: San Diego Monday, January 13, 2025, 16:30 Hrs [IST] Crinetics Pharmac ...
Pharmabiz18h
NIHR-funded research shows AI may help doctors improve the success rates of IVF treatment
NIHR-funded research shows AI may help doctors improve the success rates of IVF treatment: United Kingdom Monday, January 13, 2025, 16:00 Hrs [IST] NIHR-funded research has discov ...
Pharmabiz19h
ProMIS Neurosciences begins PRECISE-AD phase 1b trial of lead therapeutic candidate, PMN310 in Alzheimer’s disease
Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...
Pharmabiz19h
BioDuro opens new solid-phase peptide synthesis scale-up facility in China
BioDuro opens new solid-phase peptide synthesis scale-up facility in China: Irvine, California Monday, January 13, 2025, 14:30 Hrs [IST] BioDuro, a leading contract research, deve ...